Affluent Medical (France) Investor Sentiment

AFME Stock   1.42  0.03  2.16%   
About 55% of Affluent Medical's investors are presently thinking to get in. The analysis of current outlook of investing in Affluent Medical SAS suggests that some traders are interested regarding Affluent Medical's prospects. The current market sentiment, together with Affluent Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Affluent Medical SAS stock news signals to limit their universe of possible portfolio assets.
  
over three weeks ago at news.google.com         
Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a n...
Google News at Macroaxis
over a month ago at news.google.com         
Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, markin...
Google News at Macroaxis
over six months ago at news.google.com         
EQS-News Affluent Medical to attend German Fall Conference in Frankfurt in September 2024 - sharewis...
Google News at Macroaxis
over six months ago at news.google.com         
Affluent Medical focuses on commercialization after Edwards deal - BioWorld Online
Google News at Macroaxis
over six months ago at news.google.com         
Edwards pumps up to 1.65B into MA with Jenavalve and Endotronix deals - BioWorld Online
Google News at Macroaxis
over six months ago at news.google.com         
Edwards buying Innovalve Bio Medical for 300M - BioWorld Online
Google News at Macroaxis
over six months ago at news.google.com         
Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,83...
Google News at Macroaxis
over six months ago at news.google.com         
Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients wi...
Google News at Macroaxis
over six months ago at news.google.com         
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap. - sharewise
Google News at Macroaxis
over a year ago at news.google.com         
Affluent Medical hails first-in-human artificial urinary sphincter - BioWorld Online
Google News at Macroaxis
over a year ago at news.google.com         
Affluent Medical Excellent valve performance at 1 year follow up and rising recognition of Epygon bi...
Google News at Macroaxis
over a year ago at news.google.com         
Affluent Medical closes 3.5 million bridge via capital increase from key shareholders. - Marketscree...
Google News at Macroaxis
over a year ago at news.google.com         
Affluent Medical Pre-submission dossier for the 510 of medical device KaliosTM filed with FDA for re...
Google News at Macroaxis
over a year ago at news.google.com         
Age and experience a priceless combination - Restoration ... - Restoration NewsMedia
Google News at Macroaxis
over a year ago at news.google.com         
The nature of protein intake as a discriminating factor of diet ... - Nature.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Affluent Medical that are available to investors today. That information is available publicly through Affluent media outlets and privately through word of mouth or via Affluent internal channels. However, regardless of the origin, that massive amount of Affluent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Affluent Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Affluent Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Affluent Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Affluent Medical alpha.

Affluent Medical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Affluent Stock analysis

When running Affluent Medical's price analysis, check to measure Affluent Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affluent Medical is operating at the current time. Most of Affluent Medical's value examination focuses on studying past and present price action to predict the probability of Affluent Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affluent Medical's price. Additionally, you may evaluate how the addition of Affluent Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings